Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Athanasios Tselebis, Argyro Pachi, Ioannis Ilias, Epaminondas Kosmas, Dionisios Bratis, Georgios Moussas & Nikolaos Tzanakis. (2016) Strategies to improve anxiety and depression in patients with COPD: a mental health perspective. Neuropsychiatric Disease and Treatment 12, pages 297-328.
Read now
Read now
Xiao-Min Lu, Ji-Ping Zhu & Xian-Mei Zhou. (2016) The effect of benzodiazepines on insomnia in patients with chronic obstructive pulmonary disease: a meta-analysis of treatment efficacy and safety. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 675-685.
Read now
Read now
Articles from other publishers (4)
Yi-Hsiang Liao, Liang-Yu Chen, Kuang-Ming Liao & Chung-Yu Chen. (2020) Drug Safety of Benzodiazepines in Asian Patients With Chronic Obstructive Pulmonary Disease. Frontiers in Pharmacology 11.
Crossref
Crossref
Tham Thi Le, Siyeon Park, Michelle Choi, Marniker Wijesinha, Bilal Khokhar & Linda Simoni-Wastila. (2020) Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease. BMJ Open Respiratory Research 7:1, pages e000483.
Crossref
Crossref
Aurore Palmaro, Quentin Boucherie, Julie Dupouy, Joëlle Micallef & Maryse Lapeyre-Mestre. (2017) Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies?. Pharmacoepidemiology and Drug Safety 26:5, pages 544-553.
Crossref
Crossref
Anne Bénard-Laribière, Pernelle Noize, Elodie Pambrun, Fabienne Bazin, Hélène Verdoux, Marie Tournier, Bernard Bégaud & Antoine Pariente. (2016) Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine users. European Journal of Clinical Pharmacology 72:7, pages 869-876.
Crossref
Crossref